+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Pulmonary Valve System Market - Global Forecast 2026-2032- Product Image
Artificial Pulmonary Valve System Market - Global Forecast 2026-2032- Product Image
Sale

Artificial Pulmonary Valve System Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6119443
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Artificial Pulmonary Valve System Market is projected to reach USD 1.54 Billion in 2026. It is expected to continue growing at a CAGR of 13.95%, reaching USD 3.45 Billion by 2032.

Artificial Pulmonary Valve Systems: Clinical Context and Executive Overview

Artificial pulmonary valve systems restore blood flow from the right ventricle to the pulmonary artery in patients with congenital heart disease, prior right ventricular outflow tract repair, or dysfunction of an existing conduit or bioprosthetic valve. Clinical decision-making centers on anatomy, valve durability, procedural risk, hemodynamic performance, and the timing of intervention. The field includes surgical replacement and catheter-based pulmonary valve procedures, with device selection shaped by patient age, conduit characteristics, imaging findings, and institutional expertise.

From Open Repair to Anatomy-Specific, Less Invasive Intervention

The landscape is shifting toward individualized treatment pathways that combine advanced imaging, multidisciplinary review, and less invasive delivery when anatomy permits. Transcatheter approaches can reduce recovery burden for selected patients, while surgery remains important for complex anatomy, concomitant repairs, small or unsuitable conduits, and cases requiring reconstruction. Longer-term priorities include improved durability, management of residual lesions, treatment of dysfunctional prior implants, and structured lifelong surveillance for a predominantly congenital-heart population.

Artificial Intelligence Strengthens Imaging, Planning, and Follow-Up

Artificial intelligence is increasingly relevant to the interpretation of echocardiography, cardiac magnetic resonance imaging, computed tomography, and longitudinal clinical records. Potential applications include automated chamber and flow quantification, recognition of conduit or valve dysfunction, anatomical suitability assessment, procedure planning, and identification of patients who may benefit from earlier intervention. Adoption should remain clinically governed: algorithms require representative validation, transparent performance measures, data protection, interoperability with clinical systems, and prospective evaluation before influencing high-risk decisions.

Regional Insights: Uneven Access Shapes Pulmonary Valve Care

North America combines specialized congenital-heart programs, advanced imaging, and established catheter-based expertise, while access and referral timing can vary across health systems. Europe benefits from concentrated specialist networks and coordinated congenital-care pathways, although reimbursement and national access policies differ. Asia-Pacific spans highly developed centers and rapidly expanding cardiac capabilities, with affordability, training, and follow-up capacity remaining important considerations. Latin America is characterized by growing specialist activity alongside disparities in referral, diagnostics, and device availability. The Middle East is investing in tertiary cardiovascular services, with concentration of expertise in major urban centers. Africa continues to face constraints in congenital diagnosis, specialist staffing, surgical capacity, and longitudinal surveillance, making partnerships and regional referral models particularly relevant.

Group Insights: Economic and Political Blocs Influence Capacity and Standards

ASEAN markets show varied levels of congenital-heart infrastructure, with opportunities to strengthen referral networks, operator training, and post-procedure monitoring across borders. BRICS members include large and diverse healthcare systems where domestic capability, affordability, and specialist distribution strongly influence access. The European Union supports cross-border scientific and clinical collaboration, while national reimbursement and procurement rules continue to shape implementation. G7 countries generally possess mature research, imaging, and intervention ecosystems, but must address aging congenital populations and equitable access. GCC states are expanding advanced cardiac services, often through highly centralized tertiary programs. NATO members span different healthcare models, yet shared emphasis on resilience, specialist readiness, and cross-institutional collaboration can support congenital cardiovascular care.

Country Insights: Distinct Health-System Conditions Require Localized Strategies

Australia combines specialized congenital services with geographic access challenges. Brazil has substantial cardiac expertise but faces regional variation in referral and treatment availability. Canada’s specialist capacity is influenced by geography and provincial organization. China is expanding advanced cardiovascular services while addressing differences between major centers and less-served areas. France, Germany, Italy, and Spain have established congenital and interventional expertise, with access shaped by national pathways, hospital concentration, and reimbursement structures. India has leading tertiary centers alongside major disparities in affordability and specialist distribution. Japan and South Korea have sophisticated cardiac capabilities and aging congenital cohorts requiring lifelong follow-up. Mexico continues to develop specialized access amid regional and financial constraints. Russia’s capabilities and access vary by geography and institutional resources. The United Kingdom benefits from organized congenital-heart services, while the United States offers extensive specialist capacity with access influenced by insurance, referral patterns, and regional concentration.

Leadership Priorities for Safer, More Accessible Pulmonary Valve Care

Industry leaders should align product development with clearly defined anatomical use cases, durable hemodynamic performance, implantability, and practical follow-up requirements. Evidence programs should include congenital subgroups, pediatric-to-adult transition, reintervention pathways, patient-reported outcomes, and long-term safety. Partnerships with specialist centers can support training, imaging protocols, registries, and equitable referral models. Organizations should also build interoperable data infrastructure and clinically validated AI tools rather than deploying opaque systems. Regional strategies should account for reimbursement, local regulatory expectations, service capacity, and the ability to provide lifelong surveillance after implantation.

Methodology: Evidence-Led Assessment of Clinical and Health-System Drivers

This executive summary uses the defined artificial pulmonary valve system scope and synthesizes clinically relevant themes across device modalities, patient pathways, imaging, procedural practice, regulation, and healthcare delivery. Analysis is organized by region, economic or political grouping, and country to distinguish common drivers from local conditions. The assessment emphasizes verifiable clinical and system-level evidence, including congenital-heart disease management principles, technology adoption considerations, access factors, and implementation requirements. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific comparisons.

Conclusion: Durable, Coordinated Care Will Define the Field

Artificial pulmonary valve systems are developing within a broader transition toward anatomy-specific, multidisciplinary, and less invasive congenital-heart care. Progress will depend not only on device performance, but also on imaging quality, operator expertise, referral coordination, reimbursement, and lifelong surveillance. Artificial intelligence may improve planning and monitoring when validated responsibly. Leaders that combine durable clinical evidence with regional implementation strategies and equitable access initiatives will be better positioned to support safe, sustainable pulmonary valve care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Artificial Pulmonary Valve System Market, by Product Type
7.1. Introduction
7.2. Surgically Implanted Pulmonary Valve
7.2.1. Bioprosthetic Valve
7.2.2. Mechanical Valve
7.3. Transcatheter Pulmonary Valve
7.3.1. Balloon Expandable Valve
7.3.2. Self Expandable Valve
8. Artificial Pulmonary Valve System Market, by Material Type
8.1. Introduction
8.2. Mechanical Valve
8.3. Polymer Valve
8.4. Tissue Valve
8.4.1. Pericardial Tissue
8.4.2. Porcine Tissue
9. Artificial Pulmonary Valve System Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Hospitals
9.4. Specialty Clinics
10. Artificial Pulmonary Valve System Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. Artificial Pulmonary Valve System Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. Artificial Pulmonary Valve System Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. Abbott Laboratories
14.2. Affluent Medical, Inc.
14.3. Anteris Technologies Pty Ltd
14.4. Artivion, Inc.
14.5. BIOTRONIK SE & Co. KG
14.6. Boston Scientific Corporation
14.7. Braile Biomédica Indústria e Comércio S.A.
14.8. Colibri Heart Valve, LLC
14.9. Corcym S.r.l.
14.10. Edwards Lifesciences Corporation
14.11. Foldax, Inc.
14.12. Innovalve Bio Medical Ltd.
14.13. JenaValve Technology, Inc.
14.14. Labcor Laboratórios Ltda
14.15. Lepu Medical Technology Co., Ltd.
14.16. LivaNova PLC
14.17. Medtronic plc
14.18. Meril Life Sciences Pvt. Ltd.
14.19. MicroPort CardioFlow Medtech Corporation
14.20. Peijia Medical Devices Co., Ltd.
14.21. PolyVascular, Inc.
14.22. TTK Healthcare Limited
14.23. Venus MedTech (Hangzhou) Inc.
14.24. Xeltis NV
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global Artificial Pulmonary Valve System Market, Years Considered for the Study
FIGURE 2. Global Artificial Pulmonary Valve System Market, Research Design
FIGURE 3. Global Artificial Pulmonary Valve System Market, Research Framework
FIGURE 4. Global Artificial Pulmonary Valve System Market, Data Triangulation
FIGURE 5. Global Artificial Pulmonary Valve System Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Artificial Pulmonary Valve System Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Artificial Pulmonary Valve System Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Artificial Pulmonary Valve System Market Size, by Material Type, 2025 vs 2032 (%)
FIGURE 9. Global Artificial Pulmonary Valve System Market Size, by Material Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Artificial Pulmonary Valve System Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Artificial Pulmonary Valve System Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Artificial Pulmonary Valve System Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global Artificial Pulmonary Valve System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Artificial Pulmonary Valve System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global Artificial Pulmonary Valve System Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global Artificial Pulmonary Valve System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Artificial Pulmonary Valve System Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Artificial Pulmonary Valve System Market Segmentation & Coverage
TABLE 2. Global Artificial Pulmonary Valve System Market Size, 2017-2032 (USD Million)
TABLE 3. Global Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Surgically Implanted Pulmonary Valve Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Surgically Implanted Pulmonary Valve Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Surgically Implanted Pulmonary Valve Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Bioprosthetic Valve Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Bioprosthetic Valve Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Bioprosthetic Valve Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Mechanical Valve Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Mechanical Valve Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Mechanical Valve Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Transcatheter Pulmonary Valve Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Transcatheter Pulmonary Valve Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Transcatheter Pulmonary Valve Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Balloon Expandable Valve Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Balloon Expandable Valve Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Balloon Expandable Valve Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Self Expandable Valve Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Self Expandable Valve Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Self Expandable Valve Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 23. Global Mechanical Valve Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Mechanical Valve Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Mechanical Valve Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Polymer Valve Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Polymer Valve Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Polymer Valve Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Tissue Valve Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Tissue Valve Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Tissue Valve Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Pericardial Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Pericardial Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Pericardial Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Porcine Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Porcine Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Porcine Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 39. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Artificial Pulmonary Valve System Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Asia-Pacific Artificial Pulmonary Valve System Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 52. Asia-Pacific Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 56. North America Artificial Pulmonary Valve System Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. North America Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 58. North America Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 59. North America Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 60. North America Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 61. North America Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 62. North America Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 63. Latin America Artificial Pulmonary Valve System Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Latin America Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 65. Latin America Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 66. Latin America Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 67. Latin America Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 68. Latin America Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 69. Latin America Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 70. Europe Artificial Pulmonary Valve System Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Europe Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 72. Europe Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 73. Europe Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 74. Europe Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 75. Europe Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 76. Europe Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. Middle East Artificial Pulmonary Valve System Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Middle East Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 79. Middle East Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 80. Middle East Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 81. Middle East Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 82. Middle East Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 83. Middle East Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. Africa Artificial Pulmonary Valve System Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Africa Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 86. Africa Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 87. Africa Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 88. Africa Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 89. Africa Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 90. Africa Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. Global Artificial Pulmonary Valve System Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. ASEAN Artificial Pulmonary Valve System Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. ASEAN Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 94. ASEAN Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 95. ASEAN Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 96. ASEAN Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 97. ASEAN Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 98. ASEAN Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. GCC Artificial Pulmonary Valve System Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. GCC Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 101. GCC Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 102. GCC Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 103. GCC Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 104. GCC Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 105. GCC Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 106. European Union Artificial Pulmonary Valve System Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. European Union Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. European Union Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 109. European Union Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 110. European Union Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 111. European Union Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 112. European Union Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. BRICS Artificial Pulmonary Valve System Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. BRICS Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 115. BRICS Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 116. BRICS Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 117. BRICS Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 118. BRICS Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 119. BRICS Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. G7 Artificial Pulmonary Valve System Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. G7 Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 122. G7 Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 123. G7 Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 124. G7 Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 125. G7 Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 126. G7 Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. NATO Artificial Pulmonary Valve System Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. NATO Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 129. NATO Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 130. NATO Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 131. NATO Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 132. NATO Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 133. NATO Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. Global Artificial Pulmonary Valve System Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. United States Artificial Pulmonary Valve System Market Size, 2017-2032 (USD Million)
TABLE 136. United States Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 137. United States Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 138. United States Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 139. United States Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 140. United States Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 141. United States Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. Canada Artificial Pulmonary Valve System Market Size, 2017-2032 (USD Million)
TABLE 143. Canada Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 144. Canada Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 145. Canada Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 146. Canada Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 147. Canada Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 148. Canada Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. Mexico Artificial Pulmonary Valve System Market Size, 2017-2032 (USD Million)
TABLE 150. Mexico Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. Mexico Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 152. Mexico Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 153. Mexico Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 154. Mexico Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 155. Mexico Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. Brazil Artificial Pulmonary Valve System Market Size, 2017-2032 (USD Million)
TABLE 157. Brazil Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 158. Brazil Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 159. Brazil Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 160. Brazil Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 161. Brazil Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 162. Brazil Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. United Kingdom Artificial Pulmonary Valve System Market Size, 2017-2032 (USD Million)
TABLE 164. United Kingdom Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 165. United Kingdom Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 166. United Kingdom Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 167. United Kingdom Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 168. United Kingdom Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 169. United Kingdom Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. Germany Artificial Pulmonary Valve System Market Size, 2017-2032 (USD Million)
TABLE 171. Germany Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 172. Germany Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 173. Germany Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 174. Germany Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 175. Germany Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 176. Germany Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. France Artificial Pulmonary Valve System Market Size, 2017-2032 (USD Million)
TABLE 178. France Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 179. France Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 180. France Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 181. France Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 182. France Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 183. France Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. Russia Artificial Pulmonary Valve System Market Size, 2017-2032 (USD Million)
TABLE 185. Russia Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 186. Russia Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 187. Russia Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 188. Russia Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 189. Russia Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 190. Russia Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. Italy Artificial Pulmonary Valve System Market Size, 2017-2032 (USD Million)
TABLE 192. Italy Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 193. Italy Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 194. Italy Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 195. Italy Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 196. Italy Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 197. Italy Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. Spain Artificial Pulmonary Valve System Market Size, 2017-2032 (USD Million)
TABLE 199. Spain Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 200. Spain Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 201. Spain Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 202. Spain Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 203. Spain Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 204. Spain Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. China Artificial Pulmonary Valve System Market Size, 2017-2032 (USD Million)
TABLE 206. China Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 207. China Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 208. China Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 209. China Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 210. China Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 211. China Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. India Artificial Pulmonary Valve System Market Size, 2017-2032 (USD Million)
TABLE 213. India Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 214. India Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 215. India Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 216. India Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 217. India Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 218. India Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. Japan Artificial Pulmonary Valve System Market Size, 2017-2032 (USD Million)
TABLE 220. Japan Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 221. Japan Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 222. Japan Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 223. Japan Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 224. Japan Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 225. Japan Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. Australia Artificial Pulmonary Valve System Market Size, 2017-2032 (USD Million)
TABLE 227. Australia Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 228. Australia Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 229. Australia Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 230. Australia Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 231. Australia Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 232. Australia Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. South Korea Artificial Pulmonary Valve System Market Size, 2017-2032 (USD Million)
TABLE 234. South Korea Artificial Pulmonary Valve System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 235. South Korea Artificial Pulmonary Valve System Market Size, by Surgically Implanted Pulmonary Valve, 2017-2032 (USD Million)
TABLE 236. South Korea Artificial Pulmonary Valve System Market Size, by Transcatheter Pulmonary Valve, 2017-2032 (USD Million)
TABLE 237. South Korea Artificial Pulmonary Valve System Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 238. South Korea Artificial Pulmonary Valve System Market Size, by Tissue Valve, 2017-2032 (USD Million)
TABLE 239. South Korea Artificial Pulmonary Valve System Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. Global Artificial Pulmonary Valve System Market Share, by Key Player, 2025
TABLE 241. Global Artificial Pulmonary Valve System Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Affluent Medical, Inc.
  • Anteris Technologies Pty Ltd
  • Artivion, Inc.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Braile Biomédica Indústria e Comércio S.A.
  • Colibri Heart Valve, LLC
  • Corcym S.r.l.
  • Edwards Lifesciences Corporation
  • Foldax, Inc.
  • Innovalve Bio Medical Ltd.
  • JenaValve Technology, Inc.
  • Labcor Laboratórios Ltda
  • Lepu Medical Technology Co., Ltd.
  • LivaNova PLC
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort CardioFlow Medtech Corporation
  • Peijia Medical Devices Co., Ltd.
  • PolyVascular, Inc.
  • TTK Healthcare Limited
  • Venus MedTech (Hangzhou) Inc.
  • Xeltis NV

Related Topics

Related Reports

Transcatheter Pulmonary Valve Market - Global Forecast 2026-2032 - Product Image

Transcatheter Pulmonary Valve Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Artificial Biological Valve Market - Global Forecast 2026-2032 - Product Image

Artificial Biological Valve Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Transcatheter Pulmonary Valve Market Analysis: Clinical Trends, Technological Segmentation, and Strategic Landscape (2026-2031) - Product Image

Transcatheter Pulmonary Valve Market Analysis: Clinical Trends, Technological Segmentation, and Strategic Landscape (2026-2031)

  • Report
  • 128 Pages
  • Global
From
Transcatheter Pulmonary Valves - Global Strategic Business Report - Product Image

Transcatheter Pulmonary Valves - Global Strategic Business Report

  • Report
  • 366 Pages
  • Global
From
Transcatheter Pulmonary Valve Market Size by Technology, Raw Material, Application, End User, and Region 2026-2034 - Product Image

Transcatheter Pulmonary Valve Market Size by Technology, Raw Material, Application, End User, and Region 2026-2034

  • Report
  • 136 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.